Seekyo

About:

SEEKYO is a privately-owned biotech company developing the next generation of chemotherapies.

Website: https://www.seekyo-therapeutics.com/

Top Investors: Bpifrance, European Investment Fund, French Tech Acceleration Fund

Description:

Seekyo is a privately-owned biotech company that develops the next generation of chemotherapies By targeting the microenvironment of solid tumors while sparing healthy tissues, our aim is to provide treatments without adverse effects to cancer patients. Seekyo’s Smart Drugs transport potent anticancer agents in an innocuous manner toward safe tissues, provide efficient recognition of malignant specificities thanks to its targeting unit and allow the controlled release of the parent drug exclusively at the tumour site, based on its versatile enzyme-responsive self-immolative linker.

Total Funding Amount:

1.45M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Poitiers, Poitou-Charentes, France

Founded Date:

2018-01-01

Contact Email:

contact(AT)seekyo-therapeutics.com

Founders:

Oury Chetboun, Sebastien Papot

Number of Employees:

1-10

Last Funding Date:

2021-03-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai